Witkowski Leora, Goudie Catherine, Foulkes William D, McCluggage W Glenn
Department of Human Genetics, McGill University, 3755 Cote Ste Catherine, Montreal, Quebec H3T1E2, Canada.
Department of Pediatric Oncology, McGill University, 3755 Cote Ste Catherine, Montreal, Quebec H3T1E2, Canada.
Surg Pathol Clin. 2016 Jun;9(2):215-26. doi: 10.1016/j.path.2016.01.005. Epub 2016 Apr 12.
Small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is a highly malignant and aggressive tumor and is the most common undifferentiated ovarian malignancy to occur in women younger than 40. SCCOHT is characterized by deleterious germline or somatic mutations in SMARCA4. Given the striking morphologic and molecular similarities between SCCOHT and atypical teratoid/malignant rhabdoid tumor, we propose this should be reflected in a nomenclature change and that SCCOHT be renamed malignant rhabdoid tumor of the ovary. SMARCA4 (BRG1) immunohistochemistry is useful in diagnosis because there is loss of nuclear immunoreactivity in SCCOHT but retention of staining in mimics.
高钙血症型卵巢小细胞癌(SCCOHT)是一种高度恶性且侵袭性强的肿瘤,是40岁以下女性中最常见的未分化卵巢恶性肿瘤。SCCOHT的特征是SMARCA4基因发生有害的种系或体细胞突变。鉴于SCCOHT与非典型畸胎样/恶性横纹肌样瘤在形态学和分子水平上有显著相似性,我们建议这应反映在命名的改变上,即SCCOHT应重新命名为卵巢恶性横纹肌样瘤。SMARCA4(BRG1)免疫组化在诊断中很有用,因为在SCCOHT中核免疫反应性缺失,但在其模仿物中染色保留。